Please ensure Javascript is enabled for purposes of website accessibility
Home > Support > Customer Publications

Lonidamine ameliorates MASH by reducing SREBP1 and inhibiting the MAPK pathway

Release date: 2026-03-05  View count: 0
Recommendation

Get a free quote